While the mechanism of action of IGFBP subtypes is a matter of ongoing research, previous work has shown that IGFBP‐7 promotes cardiomyocyte senescence and mediates inflammatory processes in patients with heart failure with preserved ejection fraction (HFpEF) [21, 22]. Here, IGFBP7 is linked to heart failure.